Evidence map›Paper›PMID 38752787›Full record

ArticlemBio2024

Increased frequencies of highly activated regulatory T cells skewed to a T helper 1-like phenotype with reduced suppressive capacity in dengue patients.

Sotheary Sann, Borita Heng, Hoa Thi My Vo, Rebeca Arroyo Hornero, Sokchea Lay, Sopheak Sorn, Sreymom Ken, Tey Putita Ou, Denis Laurent, Chantana Yay and 6 more

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. T Cell Responses During Dengue Infection.Current topics in microbiology and immunology · 2026
    Review
  2. Dengue and severe dengue.Clinical microbiology reviews · 2025
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sotheary SannImmunology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Borita HengImmunology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Hoa Thi My VoImmunology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Rebeca Arroyo HorneroVIB Laboratory of Translational Immunomodulation, Hasselt University, Diepenbeek, Belgium.
Sokchea LayImmunology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Sopheak SornEpidemiology and Public Health Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Sreymom KenVirology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Tey Putita OuVirology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Denis LaurentKantha Bopha Children's Hospital, Phnom Penh, Cambodia.
Chantana YayJayavarman VII Hospital, Siem Reap, Cambodia.
Sowath LyEpidemiology and Public Health Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Philippe DussartVirology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.
Veasna DuongVirology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.ORCID 0000-0003-0353-1678
Anavaj SakuntabhaiDepartment of Global Health, Ecology and Emergence of Arthropod-borne Pathogens, Institut Pasteur, Université de Paris, Paris, France.
Markus Kleinewietfeld *VIB Laboratory of Translational Immunomodulation, Hasselt University, Diepenbeek, Belgium.ORCID 0000-0002-2832-3149
Tineke Cantaert *Immunology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.ORCID 0000-0002-8911-1502

Funding

Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central AfricaU01AI151758 · NIAID · INSTITUT PASTEUR · PI SAKUNTABHAI, ANAVAJ, SIMON-LORIERE, ETIENNE · 2020 to 2024
$6.7M
NIAID NIH HHS U01 AI151758Wellcome TrustWellcome Trust 208710/Z/17/Z
6 · The paper itself

Abstract

The pathogenesis of dengue involves a complex interplay between the viral factor and the host immune response. A mismatch between the infecting serotype and the adaptive memory response is hypothesized to lead to exacerbated immune responses resulting in severe dengue. Here, we aim to define in detail the phenotype and function of different regulatory T cell (Treg) subsets and their association with disease severity in a cohort of acute dengue virus (DENV)-infected Cambodian children. Treg frequencies and proliferation of Tregs are increased in dengue patients compared to age-matched controls. Tregs from dengue patients are skewed to a Th1-type Treg phenotype. Interestingly, Tregs from severe dengue patients produce more interleukin-10 after IMPORTANCE: According to the World Health Organization, dengue is the fastest-spreading, epidemic-prone infectious disease. The extent of dengue virus infections increased over the years, mainly driven by globalization-including travel and trade-and environmental changes. Dengue is an immunopathology caused by an imbalanced immune response to a secondary heterotypic infection. As regulatory T cells (Tregs) are essential in maintaining immune homeostasis and dampening excessive immune activation, this study addressed the role of Tregs in dengue immunopathology. We show that Tregs from dengue patients are highly activated, skewed to a Th1-like Treg phenotype and less suppressive compared to healthy donor Tregs. Our data suggest that Tregs fail to resolve ongoing inflammation during dengue infection and hence contribute to the immunopathology of severe dengue disease. These data clarify the role of Tregs in dengue immunopathogenesis, emphasizing the need to develop T cell-based vaccines for dengue.

Indexed as

DengueDengue VirusPhenotypeTh1 CellsT-Lymphocytes, RegulatoryAdolescentCambodiaChildChild, PreschoolFemaleHumansInterleukin-10Lymphocyte ActivationMaleInterleukin-10dengue virusFOXP3regulatory T cellssevere dengue disease

Identifiers

PMID38752787
PMCPMC11237415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.